UPDATE 1-Harvard, MIT center's gene-editing patents challenged

April 13 (Reuters) - The University of California at Berkeley and University of Vienna in Austria have appealed a ruling allowing a research center affiliated with MIT and Harvard to keep valuable patents on a revolutionary gene-editing technology known as CRISPR.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.